Cas:200815-01-6 diethoxyphosphinothioyl (2Z)-2-acetyloxyimino-2-(2-amino-1,3-thiazol-4-yl)acetate manufacturer & supplier

We serve Chemical Name:diethoxyphosphinothioyl (2Z)-2-acetyloxyimino-2-(2-amino-1,3-thiazol-4-yl)acetate CAS:200815-01-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

diethoxyphosphinothioyl (2Z)-2-acetyloxyimino-2-(2-amino-1,3-thiazol-4-yl)acetate

Chemical Name:diethoxyphosphinothioyl (2Z)-2-acetyloxyimino-2-(2-amino-1,3-thiazol-4-yl)acetate
CAS.NO:200815-01-6
Synonyms:DAIA:O,O-Diethylthiophosphoryl ( Z )-2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetate;O,O-Diethylthiophosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetate
Molecular Formula:C11H16N3O6PS2
Molecular Weight:381.36500
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:485ºC at 760 mmHg
Density:1.53g/cm3
Index of Refraction:1.619
PSA:192.47000
Exact Mass:381.02200
LogP:3.06500

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like DAIA:O,O-Diethylthiophosphoryl ( Z )-2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,O,O-Diethylthiophosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,O,O-Diethylthiophosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetate Use and application,DAIA:O,O-Diethylthiophosphoryl ( Z )-2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetate technical grade,usp/ep/jp grade.


Related News: “The jury was careful and awarded us what we’d asked for down to the penny,” Plexxikon’s lawyer Daralyn Durie told Bloomberg after the verdict came down. 2-Ethyl-1,3-thiazole-5-carboxylic acid manufacturers In 2018, the Bengaluru-based Natural Capsules set up an R&D centre in at Attibele, Bengaluru. In 2020, when PLI scheme was announced it applied for the same. 5,10-Dihydroxy-2,7-dimethyl-1,6-dihydropyrimido[4,5-g]quinazoline -4,9-dione suppliers Mene Pangalos, executive vice president, BioPharmaceuticals R&D, said: “The data being presented at EULAR add to the growing body of evidence for anifrolumab that demonstrate a compelling clinical profile with the potential to address significant unmet medical needs in this debilitating disease. 3-HYDROXY-4-METHYL-2-NITROBENZOIC ACID vendor & factory.